
Am J Psychiatry 163:521-528, March 2006
doi: 10.1176/appi.ajp.163.3.521
© 2006 American Psychiatric Association
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
William W. Eaton, Ph.D.,
Majella Byrne, Ph.D.,
Henrik Ewald, Dr.Med.Sc.,
Ole Mors, Ph.D.,
Chuan-Yu Chen, Ph.D.,
Esben Agerbo, M.S., and
Preben Bo Mortensen, M.D., Dr.Med.Sc.
OBJECTIVE: Individuals with schizophrenia and their relatives tend to have either higher or lower than expected prevalences of autoimmune disorders, especially rheumatoid arthritis, celiac disease, autoimmune thyroid diseases, and type 1 diabetes. The purpose of the study was to estimate the association of schizophrenia with these disorders as well as a range of other autoimmune diseases in a single large epidemiologic study. METHOD: The Danish Psychiatric Register, the National Patient Register, and a register with socioeconomic information were linked to form a data file that included all 7,704 persons in Denmark diagnosed with schizophrenia from 1981 to 1998 and their parents along with a sample of matched comparison subjects and their parents. The data linkage required that the autoimmune disease occur before the diagnosis of schizophrenia. RESULTS: A history of any autoimmune disease was associated with a 45% increase in risk for schizophrenia. Nine autoimmune disorders had higher prevalence rates among patients with schizophrenia than among comparison subjects (crude incidence rate ratios ranging from 1.9 to 12.5), and 12 autoimmune diseases had higher prevalence rates among parents of schizophrenia patients than among parents of comparison subjects (adjusted incidence rate ratios ranging from 1.3 to 3.8). Thyrotoxicosis, celiac disease, acquired hemolytic anemia, interstitial cystitis, and Sjögrens syndrome had higher prevalence rates among patients with schizophrenia than among comparison subjects and also among family members of schizophrenia patients than among family members of comparison subjects. CONCLUSIONS: Schizophrenia is associated with a larger range of autoimmune diseases than heretofore suspected. Future research on comorbidity has the potential to advance understanding of pathogenesis of both psychiatric and autoimmune disorders.
Related Article:
-
In This Issue
Am J Psychiatry 2006 163: A44.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. V. Seeman
Secondary Effects of Antipsychotics: Women at Greater Risk Than Men
Schizophr Bull,
April 9, 2008;
(2008)
sbn023v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Mortensen and W. W. Eaton
Diabetes Mellitus and Schizophrenia
Arch Gen Psychiatry,
February 1, 2008;
65(2):
237 - 238.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Saha, D. Chant, and J. McGrath
A Systematic Review of Mortality in Schizophrenia: Is the Differential Mortality Gap Worsening Over Time?
Arch Gen Psychiatry,
October 1, 2007;
64(10):
1123 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Juvonen, A. Reunanen, J. Haukka, M. Muhonen, J. Suvisaari, R. Arajarvi, T. Partonen, and J. Lonnqvist
Incidence of Schizophrenia in a Nationwide Cohort of Patients With Type 1 Diabetes Mellitus
Arch Gen Psychiatry,
August 1, 2007;
64(8):
894 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|